How much riboflavin should I take for migraine?

400 mg daily with food, as a single dose or 200 mg twice daily. That is the dose used in the trials; lower doses have not been shown to work.

Why is my urine bright yellow?

Unabsorbed riboflavin. It is harmless, happens to nearly everyone at this dose, and confirms you took it.

How long until it works?

The effect builds over four to twelve weeks. Judge it on a headache diary at three months.

Can I take it during an attack?

It will not help. Riboflavin is preventive only; continue your usual acute treatment.

Does it work for children?

A double-blind randomised trial in children found no benefit over placebo, so the adult evidence should not be extrapolated to childhood migraine.

Can I combine it with magnesium or CoQ10?

Yes — these are commonly stacked for migraine prophylaxis and there is no known interaction, though combined evidence is limited.

Is 400 mg safe long term?

Riboflavin is water soluble with no established upper limit and trials found adverse events comparable to placebo. Still worth reviewing annually with your clinician.

Condition

Moderate Evidence

Effectiveness 4/5

Vitamin B2 for Migraine Disorder

High-dose riboflavin is one of the few supplements with genuine randomized support in migraine prevention, cutting attack frequency by roughly half in responders at 400 mg/day.

Overview

High-dose riboflavin is one of the few supplements that appears in mainstream headache guidelines. The landmark 1998 Neurology trial found 400 mg daily reduced migraine attack frequency by around half in more than half of adult participants, and subsequent systematic reviews have kept it in the recommended tier for migraine prophylaxis on the strength of a good effect size, negligible cost and an excellent safety profile. Two caveats define its proper use. The benefit is preventive, not abortive — riboflavin does nothing for an attack in progress and takes about three months to show its full effect. And the paediatric evidence diverges: a double-blind trial in children found no advantage over placebo, so the adult result should not be extrapolated to childhood migraine.

Verdict

Likely effective

A randomised controlled trial and supporting systematic reviews show 400 mg/day riboflavin reduces adult migraine frequency by roughly half in responders over three months. A paediatric trial found no benefit.

How It Works

The working hypothesis is mitochondrial. Migraine brains show reduced phosphorylation potential and impaired oxidative metabolism between attacks, which lowers the threshold for cortical spreading depression. Riboflavin is the precursor of flavin adenine dinucleotide and flavin mononucleotide, cofactors for complex I and complex II of the electron transport chain, so supraphysiological doses are intended to restore mitochondrial ATP production rather than to correct a dietary deficiency. This explains both the dose and the delay. Nutritional requirements are met by 1.1 to 1.3 mg daily; 400 mg is roughly 300 times that, aimed at saturating flavoprotein enzymes. Because the effect depends on cumulative changes in mitochondrial enzyme activity rather than an acute pharmacological action, attack frequency typically falls over the second and third months.

Pathways involved

FAD and FMN cofactor synthesis

Mitochondrial complex I and II activity

Cerebral ATP production

Cortical spreading depression threshold

Oxidative stress handling

Dosing & Protocol

The studied prophylactic dose is 400 mg of riboflavin daily, taken as a single dose or split into two 200 mg doses. This is the dose used in the 1998 Neurology trial and carried through into the systematic reviews and guideline recommendations; lower doses have not been shown to work for migraine, and no benefit has been demonstrated above 400 mg. Take it with food. Riboflavin absorption is saturable and improves with a meal, and gastrointestinal upset is more likely on an empty stomach. Everyone taking this dose will notice bright yellow urine within a day — this is unabsorbed riboflavin, entirely harmless, and the most reliable sign that you actually took it. Judge the effect on a headache diary at three months, not on how any individual week felt.

Scenario	Dose	Form	Timing
Adult prophylaxis (trial standard)	400 mg/day	Riboflavin tablet	With food, single or split dose
Split option	200 mg twice daily	Riboflavin tablet	With breakfast and evening meal
Nutritional requirement	1.1-1.3 mg/day	Diet	For reference only, not therapeutic
Minimum trial length	3 months	-	Effect builds over weeks 4-12
Children	Not established	-	A double-blind paediatric trial found no benefit over placebo

1
Confirm the diagnosis and count the baseline· Weeks -4 to 0
Riboflavin is for migraine prophylaxis. Record attack frequency, duration and acute medication use for four weeks before starting so you have something to compare against.
2
Start 400 mg daily with food· Week 1
Single morning dose or 200 mg twice daily. Expect bright yellow urine from day one.
3
Keep the headache diary going· Months 1-3
Attacks per month and acute medication days are the endpoints that matter, not attack severity alone.
4
Continue acute treatment as normal· Ongoing
Riboflavin has no effect on an attack in progress and does not replace triptans or analgesics.
5
Review at 3 months· Month 3
A meaningful response is roughly a halving of attack frequency. No change by three months means it is not working and can be stopped.

Evidence

The 1998 Neurology randomised controlled trial of 400 mg daily against placebo over three months found significantly greater reduction in attack frequency and headache days, with a responder rate around 56% versus 19% for placebo. The 2017 systematic review in the Journal of Clinical Pharmacy and Therapeutics reviewed the accumulated riboflavin literature and concluded that adult evidence supports prophylactic use, while paediatric evidence does not. The 2019 meta-analysis in the Canadian Journal of Neurological Sciences examined vitamins and minerals for migraine prophylaxis and found riboflavin among the better-supported options, though it noted the small number of high-quality trials. Against this, the 2008 Journal of Child Neurology double-blind randomised trial of high-dose riboflavin in children found no separation from placebo — a genuinely negative result that should temper the enthusiasm, and a reminder that the adult evidence base rests on relatively few participants.

Best available evidence: One randomised placebo-controlled trial, one systematic review, one meta-analysis, one negative paediatric trial
Typical effect: Roughly halved attack frequency in adult responders; responder rate around 56% versus 19% placebo
Studied dose: 400 mg/day
Time to effect: Builds over 4-12 weeks; judge at 3 months
Population caveat: No benefit shown in children
Certainty of evidence: Moderate in adults; low and negative in children

The 1998 randomised controlled trial of 400 mg riboflavin for adult migraine prophylaxis, a systematic review and a meta-analysis of vitamins and minerals for prophylaxis, and the double-blind paediatric trial that found no benefit.

Prophylaxis of migraine headaches with riboflavin: a systematic review

Score: 7/10

2017

systematic_review

Thompson DF, Saluja HS

Adult trials generally showed reduced attack frequency at 400 mg daily, whereas paediatric trials were largely negative.

View source

Effectiveness of high-dose riboflavin in migraine prophylaxis: a randomized controlled trial

Score: 7/10

1998

rct

n=55

Schoenen J, Jacquy J, Lenaerts M

Riboflavin was superior to placebo, with 59% versus 15% of patients achieving at least a 50% reduction in attacks.

View source

Vitamins and minerals for migraine prophylaxis: a systematic review and meta-analysis

Score: 8/10

2019

meta_analysis

Okoli GN, Rabbani R, Kashani HH +3 more

Pooled estimates favoured riboflavin for reducing migraine days, with low to moderate certainty of evidence.

View source

High-dose riboflavin for migraine prophylaxis in children: a double-blind, randomized, placebo-controlled trial

Score: 7/10

2008

rct

n=48

MacLennan SC, Wade FM, Forrest KML +3 more

Riboflavin 200 mg daily produced no significant difference from placebo in children with migraine.

View source

Safety

Riboflavin has one of the cleanest safety profiles of any therapeutic-dose supplement. It is water soluble, absorption is saturable so the excess is simply excreted, and no tolerable upper intake level has been set because no reliable toxicity has been demonstrated even at doses far above 400 mg. In the trials, adverse events did not differ meaningfully from placebo. What people do report is minor: bright yellow-orange urine in essentially everyone, occasional diarrhoea, nausea or increased urinary frequency. Very rarely, high doses have been associated with photosensitivity. Riboflavin appears safe in pregnancy at nutritional doses, but 400 mg is not a nutritional dose and has not been studied in pregnancy, so prophylactic use should be discussed with a clinician. New, changing or severe headache always needs assessment before being managed as migraine.

Prevention, not rescue

Riboflavin does nothing for an attack that has already started, and the preventive effect takes up to three months to appear. Keep using your acute migraine treatment as prescribed throughout.

Interactions & Conflicts

Interacts with	Severity	Mechanism	Action
Tricyclic antidepressants and phenothiazines	low	These drugs impair riboflavin metabolism and may increase requirements	No action needed; effect favours supplementation
Tetracycline antibiotics	low	Riboflavin may reduce tetracycline absorption	Separate doses by 2 hours
Probenecid	low	Reduces renal excretion and increases riboflavin absorption	No action usually needed
Anticholinergic drugs	low	Slower gastrointestinal transit increases riboflavin absorption	No action needed
Pregnancy and breastfeeding	moderate	400 mg is far above nutritional intake and has not been studied in pregnancy	Discuss with a clinician before use
Urine-based laboratory tests	low	Fluorescence from riboflavin can interfere with some urinary assays	Mention the supplement to the laboratory

References

Frequently Asked Questions

Medical Disclaimer

The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.